# Chemtura

**Canonical:** https://apis.io/providers/chemtura/  
**Website:** https://lanxess.com  
**APIs profiled:** 0

Chemtura Corporation was a global specialty chemicals company that developed, manufactured, and marketed chemical intermediates, additives, specialty chemicals, urethanes, organometallics, and modern plastics. In April 2017, Chemtura was acquired by LANXESS AG, the German specialty chemicals company headquartered in Cologne, and its operations were integrated into LANXESS's Performance Materials and other business segments. Chemtura products are now marketed and supported through LANXESS, which continues to serve agriculture, animal care, mobility, consumer goods, electrical and electronics, energy, food, and healthcare end markets.

## Kin Score — 5.0 / 100 (minimal)

Scored 2026-08-21 under rubric 0.12.0. Trend: flat (+0.0 from 5.0).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 0.0 |
| Access Clarity | 0.0 |

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Chemtura Domain Security** — TLSv1.3 · DMARC

## Tags

Acquired, Additives, Chemical Intermediates, Chemicals, Cologne, Germany, LANXESS, Lubricants, Performance Materials, Specialty Chemicals, Urethanes, Fortune 1000

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/chemtura/). Scores are computed from the provider's own public artifacts under a published rubric.
